BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37640198)

  • 1. A three-stage eccDNA based molecular profiling significantly improves the identification, prognosis assessment and recurrence prediction accuracy in patients with glioma.
    Li Z; Wang B; Liang H; Li Y; Zhang Z; Han L
    Cancer Lett; 2023 Oct; 574():216369. PubMed ID: 37640198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ecGBMsub: an integrative stacking ensemble model framework based on eccDNA molecular profiling for improving IDH wild-type glioblastoma molecular subtype classification.
    Li Z; Wei C; Zhang Z; Han L
    Front Pharmacol; 2024; 15():1375112. PubMed ID: 38666025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating cellular heterogeneity at the single-cell level by the flexible and mobile extrachromosomal circular DNA.
    Kang J; Dai Y; Li J; Fan H; Zhao Z
    Comput Struct Biotechnol J; 2023; 21():1115-1121. PubMed ID: 36789262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative model based on clinically relevant MRI features differentiates lower grade gliomas and glioblastoma.
    Cao H; Erson-Omay EZ; Li X; Günel M; Moliterno J; Fulbright RK
    Eur Radiol; 2020 Jun; 30(6):3073-3082. PubMed ID: 32025832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease.
    Zhao S; Chi H; Yang Q; Chen S; Wu C; Lai G; Xu K; Su K; Luo H; Peng G; Xia Z; Cheng C; Lu P
    Front Immunol; 2023; 14():1090040. PubMed ID: 36825022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer.
    Zhang Y; Dong K; Jia X; Du S; Wang D; Wang L; Qu H; Zhu S; Wang Y; Wang Z; Zhang S; Sun W; Fu S
    BMC Med Genomics; 2023 Jun; 16(1):140. PubMed ID: 37337170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Role of the Apparent Diffusion Coefficient and MRI Morphologic Features on IDH Status in Patients With Diffuse Glioma: A Retrospective Cross-Sectional Study.
    Zhang J; Peng H; Wang YL; Xiao HF; Cui YY; Bian XB; Zhang DK; Ma L
    Front Oncol; 2021; 11():640738. PubMed ID: 34055608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Extrachromosomal Circular DNA Profiling of Paired Hepatocellular Carcinoma and Adjacent Liver Tissues.
    Ye J; Huang P; Ma K; Zhao Z; Hua T; Zai W; Chen J; Fu X
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data.
    Lee MH; Kim J; Kim ST; Shin HM; You HJ; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
    World Neurosurg; 2019 May; 125():e688-e696. PubMed ID: 30735871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-genome sequencing of extrachromosomal circular DNA of cerebrospinal fluid of medulloblastoma.
    Zhu Y; Liu Z; Guo Y; Li S; Qu Y; Dai L; Chen Y; Ning W; Zhang H; Ma L
    Front Oncol; 2022; 12():934159. PubMed ID: 36452490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving MGMT methylation status prediction of glioblastoma through optimizing radiomics features using genetic algorithm-based machine learning approach.
    Do DT; Yang MR; Lam LHT; Le NQK; Wu YW
    Sci Rep; 2022 Aug; 12(1):13412. PubMed ID: 35927323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region.
    Malik N; Geraghty B; Dasgupta A; Maralani PJ; Sandhu M; Detsky J; Tseng CL; Soliman H; Myrehaug S; Husain Z; Perry J; Lau A; Sahgal A; Czarnota GJ
    J Neurooncol; 2021 Nov; 155(2):181-191. PubMed ID: 34694564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
    J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma.
    Li H; He J; Li M; Li K; Pu X; Guo Y
    Front Immunol; 2022; 13():1027631. PubMed ID: 36532035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma.
    Miao Y; Liu J; Liu X; Yuan Q; Li H; Zhang Y; Zhan Y; Feng X
    Front Genet; 2022; 13():951239. PubMed ID: 36186436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.
    Cho SY; Kim S; Kim G; Singh P; Kim DW
    Sci Rep; 2019 Mar; 9(1):4599. PubMed ID: 30872592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characteristics of extrachromosomal circular DNA in patients with end-stage renal disease.
    Peng Y; Li Y; Zhang W; ShangGuan Y; Xie T; Wang K; Qiu J; Pu W; Hu B; Zhang X; Yin L; Tang D; Dai Y
    Eur J Med Res; 2023 Mar; 28(1):134. PubMed ID: 36967395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.